IAT Reinsurance’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,000
Closed -$32K 82
2025
Q3
$32K Hold
3,000
0.01% 73
2025
Q2
$29K Hold
3,000
0.01% 72
2025
Q1
$44.7K Hold
3,000
0.01% 65
2024
Q4
$44.8K Hold
3,000
0.01% 64
2024
Q3
$57.4K Hold
3,000
0.01% 61
2024
Q2
$62.1K Buy
+3,000
New +$59.6K 0.01% 60
2022
Q2
Sell
-44,256
Closed -$1.55M 96
2022
Q1
$1.55M Buy
+44,256
New +$1.51M 0.11% 56

Other funds holding OGN

IAT Reinsurance's OGN Position: Q4 2025 in Review

IAT Reinsurance sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 3,000 shares — an estimated $32K sold.

IAT Reinsurance first reported a position in OGN in Q1 2022 and held it in 7 quarters. The position peaked at $1.55M in Q1 2022. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • IAT Reinsurance reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • IAT Reinsurance sold 3,000 Organon & Co shares in Q4 2025, an estimated $32K.
  • IAT Reinsurance first reported a position in Organon & Co in Q1 2022 and held it in 7 quarters.
  • IAT Reinsurance's Organon & Co position peaked at $1.55M in Q1 2022.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on IAT Reinsurance's 13F filing for Q4 2025, filed 10 Feb 2026.